Aarkstore Enterprise -the Womens Health Market Outlook To 2015

The Womens Health Market Outlook to 2015

The Womens Health Market Outlook to 2015

The global womens health market is increasingly competitive with, very few new active substances in the pipeline with the majority of research activity focuses on development of 'me-too' products, combinations and advanced re-formulations. The Womens Health Market Outlook to 2015 provides comprehensive coverage of the global womens health market, incorporating an overview of key diseases specific to women and a detailed epidemiological analysis. It makes a wide-ranging analysis of both currently marketed products and those in the product pipeline and gives an assessment of the leading players in the market.

Scope of this research

Understand how recent events are affecting the performance of major products, and how their marketers are confronting competitive market changes.

Compare the franchises of the leading companies in global women's health market, and understand how the market share of these companies will change.

Assess key pipeline products by indication, ongoing trials, recent product launches and key developments in R&D.

Identify the challenges confronted by leading players, and understand how recent events will impact the performance of leading products.

Access forecasts of the leading marketed and pipeline products through to 2015.

Research and analysis highlights

The global women's health market was valued at $20.4bn at a Y-o-Y growth of 1%, the US dominated this market. Collectively, the top five EU markets represented the second largest womens health market with 2009 sales of $3.5bn and a market share of 17.3%.

Hormonal contraceptives with 2009 sales of $9bn represented 44.3% of the market and remained the major therapeutic class in the women's health market. Bayers Yaz and Yasmin (drospirenone + ethinyl estradiol) were the largest selling drugs in this category accounting for a market share of 24.3%.

The top 10 generic players in the global women's health market represented 68.3% of the total generic market in 2009. J&J followed by Ferring remained the market leaders in the generic women's health market.

Key reasons to purchase this research

What will be the major growth indications and the accompanying growth drivers in the womens health market over the next 6 years?

Which companies led the the womens health market in 2009?

Which products will be the future growth drivers for the womens health market?

Which therapeutic categories are forecast to have the highest levels of commercial potential over the period 200915?

Which companies are best positioned to succeed in the womens health market over the period 200915?

For more information, please contact :

http://www.aarkstore.com/reports/The-Womens-Health-Market-Outlook-to-2015-87613.html

by: aarkstore enterprise

POST COMMENT

Mens Sweatshirt And Sweater - Favourite For Men In Autumn Season Could the back pain condition take control of our daily lives What You Can Do While You Feel Sleepy At Work In Daytime Why Home Health Care Products Can Better Your Quality Of Life Top 3 Best Selling Health, Mind & Body Books Tips For A Healthy Mind and A Healthy Body Healthy Eating Advice - Finding a Balanced Diet for Healthy Nutrition Christian Health: How To Handle A Healing Crisis Health Care Workforce Use Paper Hand Towels For So Many Reasons I Wanted Smooth Legs So I Got A Hair Removal Wax Do You Know What Asthma Attack Symptoms Are To Watch For Getting your Dog to sleep! Space Tourism: What About Health Standards?